| 519510 |
11-dehydro Thromboxane B2 EIA Kit - Monoclonal
New |
|
- |
|
|
|
2012-02-08
|
215.601734960098
|
11-dehydro-thromboxane-b2-eia-kit-monoclonal
|
11-dehydro TXB2 ELISA Kit
|
11-dehydro-TXB2 enzymes immunoassays EIAs ELISAs kits assays measures measurements competitive quantification thromboxanes A2 TXA2 arachidonic acids platelets aggregation vascular bronchial smooth muscles hydrolyzed plasma urine ex vivo activation intra-renal production metabolites kidneys metabolized dehydrogenases enzymes cytosolic aldehydes peroxisomes peroxisomal b-oxidations beta-oxidations .beta.-oxidations β-oxidations infusions study studies circulating half-life t1/2 2,3-dinor 11-dehydro-2,3-dinor gas chromatography mass spectrometry GC/MS dosing doses aspirin acetylsalicylic acid NSAIDS nonsteroidal anti-inflammatory drugs smokers levels non-enzymatically |
215.601734960098
|
| 12730 |
15(S)-15-methyl Prostaglandin D2
|
|
85280-90-6 |
>95%
|
|
|
|
56.934327808471
|
15-s-15-methyl-prostaglandin-d2
|
15(S)-15-methyl PG2
|
15(S)-15-methyl-PGD2 prostaglandins vasoconstriction analogs 15S-15-methyl-PGD2 |
56.934327808471
|
| 12750 |
16,16-dimethyl Prostaglandin D2
|
|
64072-59-9 |
>98%
|
|
|
|
164.103259668509
|
16-16-dimethyl-prostaglandin-d2
|
16,16-dimethyl PGD2
|
16,16-dimethyl-PGD2 prostaglandins |
164.103259668509
|
| 13050 |
1a,1b-dihomo Prostaglandin E1
|
|
- |
>98%
|
|
|
|
19.342651933702
|
1a-1b-dihomo-prostaglandin-e1
|
1a,1b-dihomo PGE1
|
1a,1b-dihomo-PGE1 prostaglandins |
19.342651933702
|
| 9000462 |
2,3-dinor-6-keto Prostaglandin F1α-d9 (sodium salt)
|
|
- |
≥99% deuterated product
|
|
|
2010-05-07
|
20.833834254144
|
2-3-dinor-6-keto-prostaglandin-f1-d9-sodium-salt
|
2,3-dinor-6-keto PGF1α-d9 (sodium salt)
|
PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins PGs MS LC-MS LC/MS GC-MS GC/MS mass spectrometry deuterium deuterated |
20.833834254144
|
| 515121 |
2,3-dinor-6-keto Prostaglandin F1α EIA Kit
|
|
- |
|
|
|
2006-05-23
|
157.716198895028
|
2-3-dinor-6-keto-prostaglandin-f1-eia-kit
|
2,3-dinor-6-keto PGF1α ELISA Kit
|
solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays |
157.716198895028
|
| 15120 |
2,3-dinor-6-keto Prostaglandin F1α (sodium salt)
|
|
- |
≥95%
|
|
|
|
15.906215469613
|
2-3-dinor-6-keto-prostaglandin-f1-sodium-salt
|
2,3-dinor-6-keto PGF1α (sodium salt)
|
PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins |
15.906215469613
|
| 13120 |
2,3-dinor Prostaglandin E1
|
|
7046-40-4 |
>98%
|
|
|
|
31.806685082873
|
2-3-dinor-prostaglandin-e1
|
2,3-dinor PGE1
|
prostaglandins 2,3-dinor-PGE1 erectile dysfunction |
31.806685082873
|
| 11097 |
25-hydroxy Cholesterol
New |
|
2140-46-7 |
≥98%
|
|
|
2012-02-08
|
114.684567219153
|
25-hydroxy-cholesterol
|
|
16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages |
114.684567219153
|
| 11099 |
25-hydroxy Cholesterol-d6
New |
|
88247-69-2 |
≥99% deuterated form (d1-d6)
|
|
|
2012-01-27
|
104.017900552485
|
25-hydroxy-cholesterol-d6
|
|
deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages |
104.017900552485
|
| 13260 |
6-keto Prostaglandin E1
|
|
67786-53-2 |
>99%
|
|
|
|
75.689309392265
|
6-keto-prostaglandin-e1
|
6-keto PGE1
|
6-keto-PGE1 metabolites prostaglandins |
75.689309392265
|
| 10007210 |
6-keto Prostaglandin E1 Lipid Maps MS Standard
|
|
67786-53-2 |
>99%
|
|
|
2008-11-03
|
50.241491712707
|
6-keto-prostaglandin-e1-lipid-maps-ms-standard
|
6-keto PGE1
|
6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS |
50.241491712707
|
| 15210 |
6-keto Prostaglandin F1α
|
|
58962-34-8 |
>99%
|
|
|
|
56.309966850828
|
6-keto-prostaglandin-f1
|
6-keto PGF1α
|
PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis |
56.309966850828
|
| 515211 |
6-keto Prostaglandin F1α EIA Kit
|
|
- |
|
|
|
|
520.380412318396
|
6-keto-prostaglandin-f1-eia-kit
|
6-keto Prostaglandin F1α ELISA Kit
|
solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays |
520.380412318396
|
| 10007219 |
6-keto Prostaglandin F1α Lipid Maps MS Standard
|
|
58962-34-8 |
>99%
|
|
|
2008-12-17
|
37.604464088398
|
6-keto-prostaglandin-f1-lipid-maps-ms-standard
|
6-keto PGF1α
|
PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards |
37.604464088398
|
| 10010002 |
6-keto Testosterone Enanthate
Exclusive |
|
- |
>98%
|
|
✓ |
2007-07-12
|
0.206261510129
|
6-keto-testosterone-enanthate
|
|
esters androgens testosterone heptanoate analogs endocrinology |
0.206261510129
|
| 10010003 |
6α-Testosterone Enanthate
Exclusive |
|
- |
>98%
|
|
✓ |
2007-07-13
|
0.618784530387
|
6-testosterone-enanthate
|
|
esters androgens testosterone heptanoate analogs 6alpha-testosterone enanthate 6.alpha.-Testosterone enanthate endocrinology |
0.618784530387
|
| 10010004 |
6β-Testosterone Enanthate
Exclusive |
|
- |
>98%
|
|
✓ |
2007-07-13
|
0.206261510129
|
6-testosterone-enanthate
|
|
6beta-Testosterone enanthate 6.beta.-Testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology |
0.206261510129
|
| 13360 |
8-iso Prostaglandin E1
|
|
21003-46-3 |
>98%
|
|
|
|
66.538747697974
|
8-iso-prostaglandin-e1
|
Ovinonic acid; 8-iso PGE1; 8-epi PGE1
|
8-iso-PGE1 8-epi-PGE1 8-isoprostanes vasoconstriction prostaglandins |
66.538747697974
|
| 700260 |
Alanine Transaminase Activity Assay Kit
|
|
- |
|
|
|
2010-01-06
|
224.304605936926
|
alanine-transaminase-activity-assay-kit
|
ALT Activity Assay Kit; ALAT Activity Assay Kit; Alanine Aminotransferase Activity Assay Kit; sGPT Activity Assay Kit; Serum Pyruvic Transaminase Activity Assay Kit
|
alanines aminotransferases homodimeric cytoplasmic pyridoxal phosphate-enzymes cells cellular nitrogen metabolism amino acids transamination a-ketoglutarates alpha-ketoglutarates α-ketoglutarates pyruvates glutamates tissues livers kidneys heart brains glucose neuronal glutamates alanine-aminotransferases reactions diseases injury diabetes cirrhosis fatty hepatitis carcinomas mononucleosis muscular dystrophy cardiovascular serums plasmas samples lysates NADH oxidations lactate dehydrogenases LDH NAD+ assays kits measures measurements |
224.304605936926
|
| 700420 |
Ascorbate Assay Kit
|
|
- |
|
|
|
2010-09-01
|
196.081095601639
|
ascorbate-assay-kit
|
L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit
|
kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD |
196.081095601639
|
| 10532 |
BayCysLT2
Exclusive |
|
712313-33-2 |
≥95%
|
|
✓ |
2010-09-22
|
3.860902394106
|
baycyslt2
|
CAY10633
|
HAMI3379 cysLT2 receptors cardiovascular disease antagonists leukotrienes LTC4 LTD4 cysteinyl HAMI 3379 HAMI-3379 cyslts CAY10633 CAY-10633 CAY 10633 |
3.860902394106
|
| 10155 |
BM 567
|
|
284464-77-3 |
>98%
|
|
|
2005-03-31
|
51.973006445672
|
bm-567
|
|
platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege |
51.973006445672
|
| 10489 |
Candesartan cilexetil
|
|
145040-37-5 |
≥98%
|
|
|
2011-04-08
|
7.204143646409
|
candesartan-cilexetil
|
TCV-116
|
angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive |
7.204143646409
|
| 13281 |
CAY10598
Exclusive |
|
346673-06-1 |
≥98%
|
|
✓ |
2010-05-07
|
73.670928176795
|
cay10598
|
|
Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection |
73.670928176795
|
| 10012447 |
CG 4305
|
|
- |
≥95%
|
|
|
2010-05-12
|
50.951981057616
|
cg-4305
|
|
antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer
Epoprostenol Sodium
Prostaglandin I(2)
Prostaglandin I2
Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX
|
50.951981057616
|
| 600440 |
Cholesterol Uptake Cell-Based Assay Kit
|
|
- |
|
|
|
2011-06-28
|
38.823346963406
|
cholesterol-uptake-cell-based-assay-kit
|
|
assays kits measures measurements cells hormones intermediates bile acids biosynthesis body cholesterols homeostasis de novo dietary absorption biliary clearance excretion plasma hypercholesterolemia cardiovascular diseases serum hepatic Ezetimibe inhibitors inhibits inhibition intestinal uptake enterocytes proteins Niemann-Pick C1 Like 1 NPC1L1 genes influx efflux intraluminal molecules membranes modulators NBD cultured U18666A inhibitor inhibits inhibition positive controls U 18666A U-18666A |
38.823346963406
|
| 10956 |
Clofibrate
|
|
637-07-0 |
≥98%
|
|
|
2004-09-14
|
20.854229588704
|
clofibrate
|
|
PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate |
20.854229588704
|
| 13657 |
(±)-Clopidogrel (hydrochloride)
|
|
90055-48-4 |
≥98%
|
|
|
2011-04-11
|
0E-12
|
-clopidogrel-hydrochloride
|
|
platelets aggregation antagonists P2Y12 receptors ADPs prodrugs anti-thrombic antithrombic |
0E-12
|
| 13352 |
EHNA (hydrochloride)
New |
|
- |
≥98%
|
|
|
2011-10-07
|
672.662897072258
|
ehna-hydrochloride
|
|
51350-19-7 79763-32-9 59262-86-1 ADA reversible adenosine deaminase inhibitors inhibits inhibition cGMP PDE2 potent PDE1 PDE3 PDE4 phosphodiesterase ardioprotective ischemia stem cells |
672.662897072258
|
| 10005056 |
Eicosapentaenoic Acid-d5
|
|
145191-14-6 |
≥99% deuterated product
|
|
|
2005-08-30
|
232.708402836386
|
eicosapentaenoic-acid-d5
|
EPA-d5; Timnodonic Acid-d5
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory |
232.708402836386
|
| 10007432 |
FABP3 (human recombinant)
|
|
- |
>95%
|
|
|
2005-07-27
|
26.273862799262
|
fabp3-human-recombinant
|
Heart-FABP; Fatty Acid Binding Protein-3; H-FABP
|
protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology |
26.273862799262
|
| 10233 |
FABP3 Monoclonal Antibody (Clone CC68)
|
|
- |
|
|
|
2009-03-20
|
8.984487415591
|
fabp3-monoclonal-antibody-clone-cc68
|
Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP
|
antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting |
8.984487415591
|
| 10009549 |
FABP4 (human recombinant)
|
|
- |
>90%
|
|
|
2007-06-15
|
30.360148746281
|
fabp4-human-recombinant
|
Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; A-FABP; Adipocyte Fatty Acid Binding Protein; aP2
|
cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology |
30.360148746281
|
| 9001068 |
FABP4 (human recombinant) FITC conjugated
New |
|
- |
≥95%
|
|
|
2011-08-23
|
11.593022888713
|
fabp4-human-recombinant-fitc-conjugated
|
ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4
|
fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 |
11.593022888713
|
| 10010463 |
FABP4 (human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-10-23
|
5.106180939226
|
fabp4-human-recombinant-western-ready-control
|
Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting |
5.106180939226
|
| 10005191 |
FABP4 (mouse recombinant)
|
|
- |
>95%
|
|
|
2005-07-27
|
10.065867403314
|
fabp4-mouse-recombinant
|
Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP
|
protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology |
10.065867403314
|
| 10009676 |
FABP4 (mouse recombinant) Western Ready Control
|
|
- |
|
|
|
2007-04-30
|
4.295814917127
|
fabp4-mouse-recombinant-western-ready-control
|
ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis |
4.295814917127
|
| 10005368 |
Fenofibrate
|
|
49562-28-9 |
≥98%
|
|
|
2004-09-15
|
22.251700429711
|
fenofibrate
|
|
PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology |
22.251700429711
|
| 700300 |
Glucose-6-Phosphate Dehydrogenase Activity Assay Kit
|
|
- |
|
|
|
2011-07-28
|
88.633117496585
|
glucose-6-phosphate-dehydrogenase-activity-assay-kit
|
G6PDH Activity Assay Kit
|
kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent |
88.633117496585
|
| 13311 |
Gö 6983
|
|
133053-19-7 |
≥98%
|
|
|
2009-10-07
|
38.994546756701
|
g-6983
|
|
proteins kinases C PKC α β γ δ ζ µ hearts cardioprotection ischemia reperfusion injuries contractile dyfunction alpha beta gamma delta zeta micro Goe Goe6983 Go-6983 Go 6983 |
38.994546756701
|
| 10580 |
HAMI3379
Exclusive |
|
712313-35-4 |
≥90%
|
|
✓ |
2011-03-14
|
84.849629044987
|
hami3379
|
|
cysLT2 receptors cardiovascular diseases antagonists leukotrienes LTC4 LTD4 cysteinyl LTs CysLTs perfusion pressure decrease contractility cyclohexanecarboxylic acids |
84.849629044987
|
| 13705 |
HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28)
|
|
- |
|
|
|
2009-12-01
|
0E-12
|
hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 |
0E-12
|
| 13707 |
HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37)
|
|
- |
|
|
|
2009-12-01
|
0E-12
|
hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP |
0E-12
|
| 13708 |
HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28)
|
|
- |
|
|
|
2009-12-01
|
0E-12
|
hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 |
0E-12
|
| 13709 |
HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates |
0E-12
|
| 10009377 |
HDAC2 (human recombinant)
|
|
- |
>70% by SDS-PAGE
|
|
|
2006-12-06
|
30.421429588227
|
hdac2-human-recombinant
|
Histone Deacetylase 2
|
HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
30.421429588227
|
| 10009379 |
HDAC5 (human recombinant)
|
|
- |
>90% by SDS-PAGE
|
|
|
2006-12-06
|
33.230785738620
|
hdac5-human-recombinant
|
Histone Deacetylase 5
|
HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
33.230785738620
|
| 10009466 |
HDAC9 (human recombinant)
|
|
- |
>95%
|
|
|
2007-06-14
|
19.766168896397
|
hdac9-human-recombinant
|
GenBank Accession No. NM 178423; Histone Deacetylase 9
|
histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
19.766168896397
|
| 700540 |
Hemoglobin Colorimetric Assay Kit
|
|
- |
|
|
|
2011-05-23
|
128.901586249233
|
hemoglobin-colorimetric-assay-kit
|
|
kits assays measures measurements Hb Hgb globular proteins oxygen O2 lungs tissues cells carbon dioxide CO2 erythrocytes human molecules subunits chains heme groups charged iron Fe Fe2+ tetrapyrrole rings porphyrin covalent bonds monoxide nitric oxides NO hypoxia thiol S-nitrosothiol vasodilatory effects transport hypoxic red blood RBCs vessels sickle-cell anemia thalassemia bone marrow diseases kidney diabetes |
128.901586249233
|
| 13624 |
Icariin
|
|
489-32-7 |
≥97%
|
|
|
2010-02-11
|
1.738950276242
|
icariin
|
|
PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans
2 Phenyl Benzopyrans
2-Phenyl-Chromenes
2 Phenyl Chromenes
Bioflavonoids Flavonoids |
1.738950276242
|
| 13711 |
KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10
|
|
antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate |
0E-12
|
| 13714 |
Kir2.1 Potassium Channel Monoclonal Antibody (Clone S21-32)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
kir2-1-potassium-channel-monoclonal-antibody-clone-s21-32
|
|
channels antibodies western blots blotting immunoblotting WB immunohistochemistry IHC KCNJ2 genes Andersen-Tawil syndromes Andersen Tawil AT defects |
0E-12
|
| 13715 |
Kir2.2 Potassium Channel Monoclonal Antibody (Clone S24-1)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
kir2-2-potassium-channel-monoclonal-antibody-clone-s24-1
|
|
channels ions antibodies western blots blotting immunoblotting WB immunohistochemistry IHC syndromes Smith-Magenis Smith Magenis chromosomes 17 seventeen tissues genes |
0E-12
|
| 13716 |
Kir2.3 Potassium Channel Monoclonal Antibody (Clone S25-35)
|
|
- |
|
|
|
2009-12-04
|
0E-12
|
kir2-3-potassium-channel-monoclonal-antibody-clone-s25-35
|
|
antibodies channels ions western blots blotting immunoblotting WB IHC immunohistochemistry genes proteins potassiums |
0E-12
|
| 13810 |
Limaprost
|
|
74397-12-9 |
>98%
|
|
|
|
43.118038674033
|
limaprost
|
17α,20-dimethyl-Δ2-Prostaglandin E1; 17α,20-dimethyl-Δ2-PGE1
|
PGE1 analogs inhibitors platelets aggregation prostaglandins |
43.118038674033
|
| 390150 |
Linoleic Acid-d4
Exclusive |
|
79050-23-0 |
≥99% deuterated product
|
|
✓ |
|
17.203977900552
|
linoleic-acid-d4
|
|
standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids |
17.203977900552
|
| 16833 |
Lisinopril
|
|
76547-98-3 |
≥98%
|
|
|
2009-03-09
|
2.545248618785
|
lisinopril
|
MK 522; MK 521
|
inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes |
2.545248618785
|
| 13357 |
Milrinone
|
|
78415-72-2 |
≥98%
|
|
|
2011-03-07
|
274.534618088485
|
milrinone
|
Primacor®; WIN 47203
|
inhibitors phosphodiesterases PDE3A PDE3B cAMP vascular diseases cardiovascular effects Sanofi Synthelabo Brand of Milrinone Lactate
Sanofi Winthrop Brand of Milrinone Lactate
Sanofi Synthelabo Brand of Milrinone
Sanofi Brand of Milrinone Lactate Lactate Milrinone Milrinone Lactate Win-47203 Win 47203 Milrinone Corotrope Win47203 Primacor Corotrop inhibits inhibition |
274.534618088485
|
| 585001 |
Myeloperoxidase (human) EIA Kit
|
|
- |
|
|
|
2009-05-05
|
34.039981583793
|
myeloperoxidase-human-eia-kit
|
MPO (human) EIA Kit
|
myeloperoxidases controls standards EIAs ELISAs enzymes immunometrics assays leukocytes oxidants atherosclerotic atherosclerosis plaques prothrombogenicity cytotoxic cytotoxins nitric oxides vasocontrictions vasocontrictors plasma blood ACS acute coronary syndromes cardiac myocardial infarction revascularization death assays |
34.039981583793
|
| 700170 |
Myeloperoxidase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-04-14
|
94.095513812154
|
myeloperoxidase-inhibitor-screening-assay-kit
|
MPO Inhibitor Screening Assay Kit
|
heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays |
94.095513812154
|
| 700160 |
Myeloperoxidase Peroxidation Assay Kit
|
|
- |
|
|
|
2009-04-14
|
108.479337016574
|
myeloperoxidase-peroxidation-assay-kit
|
MPO Peroxidation Assay Kit
|
heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin |
108.479337016574
|
| 9000537 |
N-Desethylamiodarone (hydrochloride)
|
|
96027-74-6 |
≥95%
|
|
|
2009-10-07
|
0.486187845304
|
n-desethylamiodarone-hydrochloride
|
MDEA
|
substrates CYP3A4 metabolites amiodarone cytochromes CYP-3A4 CYP 3A4 |
0.486187845304
|
| 11106 |
Nifedipine
New |
|
21829-25-4 |
≥98%
|
|
|
2011-11-22
|
12.462962962963
|
nifedipine
|
Nifediac™; BAY 1040; Procardia™; Nifedical™; Cordipin; Adalat™
|
dihydropyridine calcium channel blockers Ca2+ hypertension angina endothelia cardiology preterm labor Raynaud’s phenomenon pulmonary edema coronary vasodilator antioxidant gastric acids 11104-22-6 101539-70-2 101554-38-5 adalat nifediac cordipin procardia nifedical adalate adapine adapress alat alfadat alonix angipec anifed BAY-1040 BAY1040 BAY-a BAYa BAY-a 1040 bonacid calcigard calcibloc calciguard calcilat camont cardifen cardionorm chronadalate coral cordafen cordaflex cordilan corinfar corotrend corynphar depin dignokonstant dilafed dilcor duranifin ecodipin fedcor fenamon fedipin fenihidine glopir hadipine hexadilat introcar kordafen macorel megalat myogard nifedilat nifedirex nifelantern nifelat nifensar niphedipine nyefax orix oxcord pidilat procardia sepamit TN 873R TN-873R TN873R tensopin tibricol UV-ENP 349PINa vasdalat vasofed xinran zenusin |
12.462962962963
|
| 10010653 |
Nisoldipine-d3
|
|
- |
≥99% deuterated product
|
|
|
2009-04-15
|
0E-12
|
nisoldipine-d3
|
|
63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry |
0E-12
|
| 10350 |
PRMT1 (human recombinant)
|
|
- |
≥80%
|
|
|
2011-01-25
|
81.133581952118
|
prmt1-human-recombinant
|
Protein Arginine Methyltransferase 1
|
PRMT1 brucei Prmt1 TbPRMT1 brucei Silencing Factors Transcriptional Transcriptional Silencing Factors Transcription Factors Repressor Molecules Proteins Repressor Repressor Proteins arginine methyltransferase histones modification glycine arginine rich GAR motifs SAM-dependent GST-tagged |
81.133581952118
|
| 10752 |
PRMT6 (human recombinant)
New |
|
- |
≥80%
|
|
|
2012-01-24
|
90.398209978586
|
prmt6-human-recombinant
|
Protein Arginine Methyltransferase 6; HRMT1L6; Histone Arginine N-methyltransferase PRMT6; Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 6
|
PRMTs arginine methyltransferases epigenetics PRMT6 histones SAM MMA aDMA H3R2 HMA H3K4 MLL HMGA1a |
90.398209978586
|
| 512031 |
Prostaglandin D2 EIA Kit
|
|
- |
|
|
|
2010-07-19
|
268.101938305709
|
prostaglandin-d2-eia-kit
|
PGD2 ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
268.101938305709
|
| 512041 |
Prostaglandin D2 Express EIA Kit
|
|
- |
|
|
|
2010-07-19
|
125.652167445813
|
prostaglandin-d2-express-eia-kit
|
PGD2 Express ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
125.652167445813
|
| 12990 |
Prostaglandin D3
Exclusive |
|
71902-47-1 |
>98%
|
|
✓ |
|
74.783775322283
|
prostaglandin-d3
|
PGD3
|
PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins |
74.783775322283
|
| 13010 |
Prostaglandin E1
|
|
745-65-3 |
>98%
|
|
|
|
56.894554941681
|
prostaglandin-e1
|
Alprostadil; PGE1
|
PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 |
56.894554941681
|
| 13010.1 |
Prostaglandin E1 Analytical Reference Standard
|
|
745-65-3 |
>99%
|
|
|
|
31.944162062615
|
prostaglandin-e1-analytical-reference-standard
|
Alprostadil; PGE1
|
PGE1 vasodilation USP erectile dysfunction prostaglandins |
31.944162062615
|
| 13082 |
Resorcinolnaphthalein
|
|
41307-63-5 |
≥98%
|
|
|
2009-02-24
|
63.218314917127
|
resorcinolnaphthalein
|
NSC 354317
|
angiotensin converting enzyme 2 ACE2 hypertension blood pressure activators fibrosis |
63.218314917127
|
| 10012555 |
Sodium Hydrogen Sulfide (hydrate)
|
|
207683-19-0 |
≥65%
|
|
|
2009-09-03
|
26.704851647227
|
sodium-hydrogen-sulfide-hydrate
|
Sodium Hydrosulfide; NSC 158264; NaHS
|
hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 |
26.704851647227
|
| 10162 |
Treprostinil
|
|
81846-19-7 |
>98%
|
|
|
2005-08-30
|
218.580605605111
|
treprostinil
|
Remodulin®
|
primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® |
218.580605605111
|
| 18113 |
YM-53601
Exclusive |
|
182959-33-7 |
≥98%
|
|
✓ |
2009-08-11
|
5.105911602209
|
ym-53601
|
|
squalene synthases inhibitors cholesterol triglycerides HMG-CoA reductase fibrates hyperlipidemia hypercholesterolemia lipid-lowering activities inhibitor inhibited |
5.105911602209
|
| 90210 |
α-Linolenic Acid
|
|
463-40-1 |
>98%
|
|
|
|
13.113828729281
|
-linolenic-acid
|
ALA
|
fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic |
13.113828729281
|
| 9000433 |
α-Linolenic Acid-d14
|
|
- |
≥99% deuterated product
|
|
|
2010-09-13
|
7.645997544506
|
-linolenic-acid-d14
|
ALA-d14
|
fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic |
7.645997544506
|
| 10010001 |
Δ-6 Testosterone Enanthate
Exclusive |
|
- |
>98%
|
|
✓ |
2007-07-12
|
0.206261510129
|
-6-testosterone-enanthate
|
|
DELTA-6-testosterone enanthate .DELTA.-6-testosterone enanthate .DELTA.6-testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology |
0.206261510129
|